European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN) Decision follows positive recommendation ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary immunoglobulin A (IgA ... also known as Berger's disease, progress to kidney ...

This provided the funding needed to take its formulation of budesonide into late stage trials for the rare disease, IgA nephropathy, also known as Berger’s disease or IgAN. Its technology is ...

After a few more appointments and tests, it was discovered he was at 5% kidney function and diagnosed with IgA nephropathy, also known as Berger's disease, which is a chronic kidney disease ...

to treat primary immunoglobulin A nephropathy (IgAN), also known as Berger’s disease. Vanrafia is a once-daily, non-steroidal, oral treatment that can be added onto supportive care, including a ...

For more information about CSL Vifor visit, cslvifor.com. About IgA Nephropathy (IgAN) IgAN, also called Berger’s disease, is a rare progressive kidney disease characterized by the buildup of ...